Benjamin Daquioag.
Phone number 713-526-9821 ext217

GS-US-334-0123

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subject

Copyright © 2017. Cure C Consortium